Abstract:Abstract The circadian system temporally regulates physiology to maintain homeostasis. Co-opting and disrupting circadian signals appear to be distinct attributes that are functionally important for the development of a tumor and can enable or give rise to the hallmarks that tumors use to facilitate their initiation, growth and progression. Because circadian signals are also strong regulators of immune cell proliferation, trafficking and exhaustion states, they play a role in how tumors respond to immune-based cancer therapeutics. While immuno-oncology has heralded a paradigm shift in cancer therapeutics, greater accuracy is needed to increase our capability of predicting who will respond favorably to, or who is likely to experience the troubling adverse effects of, immunotherapy. Insights into circadian signals may further refine our understanding of biological determinants of response and help answer the fundamental question of whether certain perturbations in circadian signals interfere with the activity of immune checkpoint inhibitors. Here we review the body of literature highlighting circadian disruption as a cancer promoter and synthesize the burgeoning evidence suggesting circadian signals play a role in how tumors respond to immune-based anti-cancer therapeutics. The goal is to develop a framework to advance our understanding of the relationships between circadian markers, cancer biology, and immunotherapeutics. Bolstered by this new understanding, these relationships may then be pursued in future clinical studies to improve our ability to predict which patients will respond favorably to, and avoid the adverse effects of, traditional and immune-based cancer therapeutics.

The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer

Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

Integration of circadian rhythms and immunotherapy for enhanced precision in brain cancer treatment

The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics

Circadian Rhythms in Anticancer Immunity: Mechanisms and Treatment Opportunities

Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis

Circadian disruption and cancer- and treatment-related symptoms

Clocking cancer immunotherapy responses

Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life

Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response

Impact of Circadian Rhythms on the Development and Clinical Management of Genitourinary Cancers

Sleep and gynecological cancer outcomes: opportunities to improve quality of life and survival

Circadian rhythms and new options for novel anticancer therapies

Effect of exercise based interventions on sleep and circadian rhythm in cancer survivors—a systematic review and meta-analysis

Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy

Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy

Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?

Research Progress of Circadian Rhythm Disorder in Cancer Survivors

Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

The rhythm of the night